LanchoteVLBonatoPSCamposGMRodriguesI. Factors influencing plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic children and adults. Ther Drag Monit1995;17: 47–52.
2.
AndersonGD. A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother1998;32: 554–63.
3.
KerrBMThummelKEWurdenCJKleinSMKroeczDLGonzalezFHuman liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol1994;47: 1969–79.
4.
GreeneDSBarbhaiyaRH. Clinical pharmacokinetics of nefazodone. Clin Pharmacokinet1997;33: 260–75.
5.
AshtonAKWolinRE. Nefazodone-induced carbamazepine toxicity (letter). Am J Psychiatry1996;153: 733.